The neuroendocrine system modulates the immune response through neurop
eptides and neurohormones, findings which point to the existence of a
neuro-endocrine-immune system regulatory axis. At the same time, there
is growing evidence that the pineal gland has anti-neoplastic propert
ies, which include the action of its principal hormone, melatonin (MLT
) on the immune system through the release of cytokines by activated T
-cells and monocytes. The present study was carried out on 3l patients
(19 males and 12 females age range 46-73 years) with advanced solid t
umors (7 gastric, 9 enteric, 8 renal, 5 bladder, 2 prostate) who eithe
r failed to respond to chemotherapy and radiotherapy or showed insigni
ficant responses and were therefore shifted to MLT therapy (10 mg/die
orally for 3 months). We obtained blood samples just before the start
of MLT administration and after 30 days of therapy. Plasma was collect
ed in EDTA tubes on ice, immediately centrifuged at 4 degrees C and st
ored frozen at -80 degrees C; samples were measured by immunoradiometr
ic assays (Medgenix - Fleurus, Belgium) for tumor necrosis factor alph
a (TNF) interleukin-1, 2 and 6 (IL-1, IL-2, IL-6) and interferon gamma
(IFN). We used Student's paired t-test to compare each patient's cyto
kine circulating levels before and after MLT administration and found
a significant differences (p < 0.05). After 3 months of therapy, none
of our patients displayed adverse reactions to MLT or had to discontin
ue treatment. Nineteen patients (61%) showed disease progression. The
other 12 (39%), however, achieved disease stabilization with no furthe
r growth of either the primary tumor or of secondaries; moreover, they
experienced an improvement in their general well-being, in terms of T
chekmedyian's criteria, associated with a significative decrease of IL
-6 circulating levels. These findings are consistent with the hypothes
is that MLT modulates immune function in cancer patients by activating
the cytokine system which exerts growth-inhibitory properties over a
wide range of tumor cell types. Furthermore, by stimulating the cytoto
xic activity of macrophages and monocytes, MLT plays a critical role i
n host defence againist the progression of neoplasia.